What are the causes of elevated Red Cell Distribution Width (RDW)?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: November 24, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Causes of Elevated Red Cell Distribution Width (RDW)

Elevated RDW (>14.0%) reflects heterogeneous red blood cell volumes and most commonly indicates iron deficiency anemia, but also occurs with vitamin B12/folate deficiency, hemolysis, inflammatory conditions, and mixed anemia states. 1

Primary Hematologic Causes

Iron Deficiency Anemia

  • Iron deficiency is the most common cause of elevated RDW, particularly when combined with microcytosis (low MCV). 1
  • The elevated RDW reflects the wide variation in red cell sizes as iron-deficient erythropoiesis produces progressively smaller cells alongside older normal-sized cells. 2
  • Diagnosis requires serum ferritin <30 μg/L in the absence of inflammation, or <100 μg/L when inflammation is present. 3, 1
  • Transferrin saturation <16-20% and raised total iron-binding capacity support the diagnosis. 3

Vitamin Deficiencies

  • Vitamin B12 and folate deficiency cause elevated RDW, though 31% of untreated pernicious anemia patients may have normal RDW values. 4
  • These deficiencies produce macrocytic anemia with high RDW due to ineffective erythropoiesis creating variable cell sizes. 2
  • Normal RDW does not exclude B12 deficiency, particularly in early stages, making it a less reliable marker than for iron deficiency. 4

Hemolytic Anemia

  • Hemolysis elevates RDW due to the mixture of young reticulocytes (larger) and fragmented or damaged red cells. 2
  • The shortened red cell lifespan and compensatory increased erythropoiesis create marked size heterogeneity. 5

Mixed Anemia States

  • When microcytosis and macrocytosis coexist (producing normal MCV), elevated RDW is the key diagnostic clue. 1
  • This occurs with combined iron and B12/folate deficiency, or iron deficiency in patients on thiopurine therapy. 3

Inflammatory and Chronic Disease Causes

Chronic Inflammation

  • Inflammatory conditions elevate RDW through multiple mechanisms including impaired erythropoiesis, oxidative stress, and altered iron metabolism. 2, 5
  • In inflammatory bowel disease, RDW helps distinguish iron deficiency from anemia of chronic disease or mixed patterns. 3
  • Anemia of chronic disease typically shows ferritin >100 μg/L with transferrin saturation <20%. 3

Acute COVID-19 and Post-Viral Syndromes

  • Substantial RDW increases occur during acute COVID-19 due to erythrocyte membrane injury, reduced deformability, and complement deposition on red cells. 3
  • Inflammatory secretory phospholipase A₂ IIA metabolizes phospholipids in erythrocytes, contributing to membrane damage. 3
  • Similar erythrocyte pathology occurs in other post-viral conditions like ME/CFS. 3

Metabolic and Systemic Causes

Oxidative Stress and Metabolic Derangements

  • Elevated RDW reflects underlying metabolic imbalances including oxidative stress, inflammation, poor nutritional status, and dyslipidemia. 5
  • These factors impair both erythropoiesis and red blood cell survival, creating anisocytosis. 5
  • Shortened telomere length, altered erythropoietin function, and erythrocyte fragmentation contribute to RDW elevation. 5, 6

Cardiovascular and Chronic Organ Disease

  • RDW elevation occurs in cardiovascular disease, liver failure, kidney failure, and diabetes through inflammation and oxidative stress pathways. 5
  • In coronary artery disease, elevated RDW predicts poor outcomes due to decreased red cell deformability impairing microcirculation. 6

Cancer

  • Lung cancer patients show elevated RDW associated with increased eryptosis (programmed red cell death) and accelerated red cell turnover. 3
  • Cytostatic agents, particularly platinum-based drugs, induce eryptosis and worsen anemia with elevated RDW. 3

Diagnostic Approach

Initial Workup

  • Minimum evaluation includes complete blood count with MCV, reticulocyte count, serum ferritin, transferrin saturation, and CRP. 1
  • Peripheral blood smear assessment for red cell morphology, schistocytes, and hemolysis is essential. 7

Interpretation by MCV Pattern

  • Microcytic anemia (low MCV) + high RDW = iron deficiency anemia until proven otherwise. 1
  • Normocytic anemia + high RDW = early iron deficiency, vitamin deficiency, or hemolysis. 1
  • Normal MCV + high RDW = mixed deficiency states (iron plus B12/folate). 1

Common Pitfalls

  • Nearly half of thalassemia cases may show elevated RDW, limiting its specificity for distinguishing from iron deficiency. 8
  • RDW values vary between laboratory instruments; always use the specific laboratory's reference range. 1
  • Normal RDW does not exclude vitamin B12 deficiency, particularly in early stages. 4
  • Do not empirically treat with iron based solely on elevated RDW without confirming iron deficiency with ferritin and transferrin saturation. 7

References

Guideline

Interpreting Red Cell Distribution Width (RDW) Values

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Guideline

Guideline Directed Topic Overview

Dr.Oracle Medical Advisory Board & Editors, 2025

Research

Red blood cell distribution width in untreated pernicious anemia.

American journal of clinical pathology, 1988

Research

Red blood cell distribution width: A simple parameter with multiple clinical applications.

Critical reviews in clinical laboratory sciences, 2015

Guideline

Management of Low RDW with High NRBC

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.